只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-15 2026-07-16 | ENVA Enova International, Inc. | Fisher David Director,Officer · Executive Chairman | 卖出（S） | 11,494 | US$231.45 | US$266.03万 | 306,444 | SEC |
| 2026-07-14 2026-07-16 | ENVA Enova International, Inc. | Fisher David Director,Officer · Executive Chairman | 卖出（S） | 17,006 | US$231.51 | US$393.7万 | 306,444 | SEC |
| 2026-06-18 2026-06-23 | ENVA Enova International, Inc. | TEBBE MARK Director | 卖出（S） | 20,000 | US$201.37 | US$402.74万 | 50,029 | SEC |
| 2026-06-17 2026-06-22 | ENVA Enova International, Inc. | Fisher David Director,Officer · Executive Chairman | 卖出（S） | 33,060 | US$199.05 | US$658.06万 | 306,444 | SEC |
| 2026-06-16 2026-06-16 | ENVA Enova International, Inc. | GOODYEAR WILLIAM M Director | 卖出（S） | 3,500 | US$188.02 | US$658,070.00 | 50,820 | SEC |
| 2026-06-15 2026-06-16 | ENOV Enovis CORP | Engert Oliver Officer · Chief Administrative Officer | 买入（P） | 1,000 | US$20.92 | US$20,920.00 | 53,640 | SEC |
| 2026-06-11 2026-06-15 | ENOV Enovis CORP | Engert Oliver Officer · Chief Administrative Officer | 买入（P） | 1,000 | US$21.75 | US$21,750.00 | 51,840 | SEC |
| 2026-06-11 2026-06-15 | ENOV Enovis CORP | Engert Oliver Officer · Chief Administrative Officer | 买入（P） | 200 | US$20.99 | US$4,198.00 | 50,840 | SEC |
| 2026-06-10 2026-06-11 | ENOV Enovis CORP | Engert Oliver Officer · Chief Administrative Officer | 买入（P） | 1,000 | US$23.00 | US$23,000.00 | 50,640 | SEC |
| 2026-06-01 2026-06-03 | ENVA Enova International, Inc. | GOODYEAR WILLIAM M Director | 卖出（S） | 5,983 | US$163.13 | US$976,006.79 | 62,757 | SEC |
| 2026-06-01 2026-06-03 | ENOV Enovis CORP | Engert Oliver Officer · Chief Administrative Officer | 买入（P） | 1,000 | US$22.22 | US$22,220.00 | 49,640 | SEC |
| 2026-05-29 2026-06-02 | ENVA Enova International, Inc. | RICE LINDA JOHNSON Director | 卖出（S） | 1,300 | US$161.20 | US$209,560.00 | 6,277 | SEC |
| 2026-05-22 2026-05-26 | ENVA Enova International, Inc. | Fisher David Director,Officer · Executive Chairman | 卖出（S） | 3,076 | US$158.45 | US$487,392.20 | 306,444 | SEC |
| 2026-05-21 2026-05-26 | ENVA Enova International, Inc. | Fisher David Director,Officer · Executive Chairman | 卖出（S） | 7,180 | US$160.37 | US$115.15万 | 306,444 | SEC |
| 2026-05-20 2026-05-21 | NONE Keenova Therapeutics plc | Silver Point Capital L.P. TenPercentOwner | 买入（P） | 210,000 | US$90.50 | US$1900.5万 | 6,035,214 | SEC |
| 2026-05-20 2026-05-21 | NONE Keenova Therapeutics plc | O'Shea Robert J TenPercentOwner | 买入（P） | 210,000 | US$90.50 | US$1900.5万 | 6,035,214 | SEC |
| 2026-05-20 2026-05-21 | NONE Keenova Therapeutics plc | MULE EDWARD A TenPercentOwner | 买入（P） | 210,000 | US$90.50 | US$1900.5万 | 6,035,214 | SEC |
| 2026-05-19 2026-05-21 | NONE Keenova Therapeutics plc | Silver Point Capital L.P. TenPercentOwner | 买入（P） | 187,500 | US$90.50 | US$1696.88万 | 5,825,214 | SEC |
| 2026-05-19 2026-05-21 | NONE Keenova Therapeutics plc | O'Shea Robert J TenPercentOwner | 买入（P） | 187,500 | US$90.50 | US$1696.88万 | 5,825,214 | SEC |
| 2026-05-19 2026-05-21 | NONE Keenova Therapeutics plc | MULE EDWARD A TenPercentOwner | 买入（P） | 187,500 | US$90.50 | US$1696.88万 | 5,825,214 | SEC |
| 2026-05-19 2026-05-21 | RNXT RenovoRx, Inc. | VOLL MARK Officer · Chief Financial Officer | 买入（P） | 25,000 | US$0.79 | US$19,750.00 | 142,380 | SEC |
| 2026-05-18 2026-05-20 | ENVA Enova International, Inc. | GOODYEAR WILLIAM M Director | 卖出（S） | 6,231 | US$166.08 | US$103.48万 | 68,740 | SEC |
| 2026-05-07 2026-05-11 | ENVA Enova International, Inc. | Fisher David Director,Officer · Executive Chairman | 卖出（S） | 20,000 | US$173.18 | US$346.36万 | 306,444 | SEC |
| 2026-04-28 2026-04-30 | ENVA Enova International, Inc. | Cunningham Steven E Director,Officer · Chief Executive Officer | 卖出（S） | 4,156 | US$175.50 | US$729,378.00 | 122,945 | SEC |
| 2026-04-28 2026-04-30 | ENVA Enova International, Inc. | Cunningham Steven E Director,Officer · Chief Executive Officer | 卖出（S） | 3,696 | US$175.50 | US$648,648.00 | 122,945 | SEC |
| 2026-04-17 2026-04-17 | NONE Keenova Therapeutics plc | MULE EDWARD A TenPercentOwner | 买入（P） | 410,000 | US$90.50 | US$3710.5万 | 5,637,714 | SEC |
| 2026-04-17 2026-04-17 | NONE Keenova Therapeutics plc | O'Shea Robert J TenPercentOwner | 买入（P） | 410,000 | US$90.50 | US$3710.5万 | 5,637,714 | SEC |
| 2026-04-17 2026-04-17 | NONE Keenova Therapeutics plc | Silver Point Capital L.P. TenPercentOwner | 买入（P） | 410,000 | US$90.50 | US$3710.5万 | 5,637,714 | SEC |
| 2026-04-15 2026-04-17 | NONE Keenova Therapeutics plc | MULE EDWARD A TenPercentOwner | 买入（P） | 275,000 | US$88.50 | US$2433.75万 | 5,227,714 | SEC |
| 2026-04-15 2026-04-17 | NONE Keenova Therapeutics plc | O'Shea Robert J TenPercentOwner | 买入（P） | 275,000 | US$88.50 | US$2433.75万 | 5,227,714 | SEC |
| 2026-04-15 2026-04-17 | NONE Keenova Therapeutics plc | Silver Point Capital L.P. TenPercentOwner | 买入（P） | 275,000 | US$88.50 | US$2433.75万 | 5,227,714 | SEC |
| 2025-12-08 2026-05-15 | ULS UL Solutions Inc. | Genovesi John A Officer · See Remarks | 买入（P） | 30 | US$77.82 | US$2,334.60 | 31,080 | SEC |
| 2025-09-08 2026-05-15 | ULS UL Solutions Inc. | Genovesi John A Officer · See Remarks | 买入（P） | 37 | US$63.59 | US$2,352.83 | 31,050 | SEC |
| 2025-06-09 2026-05-15 | ULS UL Solutions Inc. | Genovesi John A Officer · See Remarks | 买入（P） | 33 | US$70.43 | US$2,324.19 | 31,013 | SEC |
| 2025-03-10 2026-05-15 | ULS UL Solutions Inc. | Genovesi John A Officer · See Remarks | 买入（P） | 45 | US$52.32 | US$2,354.40 | 30,980 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| ENOV | 169,639.0029 | 0 | 276,247.6557 | 61.41% | B, Q, N |